1. Home
  2. VTMX vs LGND Comparison

VTMX vs LGND Comparison

Compare VTMX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • LGND
  • Stock Information
  • Founded
  • VTMX 1998
  • LGND 1987
  • Country
  • VTMX Mexico
  • LGND United States
  • Employees
  • VTMX N/A
  • LGND N/A
  • Industry
  • VTMX
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTMX
  • LGND Health Care
  • Exchange
  • VTMX Nasdaq
  • LGND Nasdaq
  • Market Cap
  • VTMX 2.2B
  • LGND 2.3B
  • IPO Year
  • VTMX 2023
  • LGND 1992
  • Fundamental
  • Price
  • VTMX $26.21
  • LGND $113.15
  • Analyst Decision
  • VTMX Buy
  • LGND Strong Buy
  • Analyst Count
  • VTMX 2
  • LGND 6
  • Target Price
  • VTMX $33.50
  • LGND $145.00
  • AVG Volume (30 Days)
  • VTMX 168.5K
  • LGND 131.4K
  • Earning Date
  • VTMX 02-12-2025
  • LGND 11-07-2024
  • Dividend Yield
  • VTMX 2.76%
  • LGND N/A
  • EPS Growth
  • VTMX 2.33
  • LGND 160.46
  • EPS
  • VTMX 0.39
  • LGND 2.47
  • Revenue
  • VTMX $243,239,612.00
  • LGND $152,422,000.00
  • Revenue This Year
  • VTMX N/A
  • LGND $26.86
  • Revenue Next Year
  • VTMX $21.87
  • LGND $14.54
  • P/E Ratio
  • VTMX $6.36
  • LGND $45.87
  • Revenue Growth
  • VTMX 18.11
  • LGND N/A
  • 52 Week Low
  • VTMX $23.32
  • LGND $67.53
  • 52 Week High
  • VTMX $41.44
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 57.08
  • LGND 44.98
  • Support Level
  • VTMX $25.13
  • LGND $111.00
  • Resistance Level
  • VTMX $26.23
  • LGND $117.54
  • Average True Range (ATR)
  • VTMX 0.69
  • LGND 5.75
  • MACD
  • VTMX 0.15
  • LGND -1.05
  • Stochastic Oscillator
  • VTMX 76.26
  • LGND 14.12

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is a real estate company dedicated to the development and leasing of industrial buildings and distribution centers in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenues is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: